Abstract
The primary objective of this study is to evaluate a potential behavioral intervention
(MED-Go app). To meet this objective, the researchers will conduct a pilot randomized
controlled trial to test the feasibility and acceptability of MED-Go app in adolescents and
young adults (AYA) with sickle cell disease (SCD). The long-term goal of this research is to
promote medication adherence behavior and improve health outcomes in AYA with SCD.
